Cellectis SA (CLLS)
1.85
-0.01
(-0.54%)
USD |
NASDAQ |
Nov 22, 12:56
Cellectis Enterprise Value: -28.39M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -28.39M |
| November 20, 2024 | -23.38M |
| November 19, 2024 | -18.38M |
| November 18, 2024 | -20.38M |
| November 15, 2024 | -27.39M |
| November 14, 2024 | -23.38M |
| November 13, 2024 | -16.38M |
| November 12, 2024 | -16.88M |
| November 11, 2024 | -23.38M |
| November 08, 2024 | -37.40M |
| November 07, 2024 | -39.40M |
| November 06, 2024 | -37.40M |
| November 05, 2024 | -36.39M |
| November 04, 2024 | -38.40M |
| November 01, 2024 | -34.39M |
| October 31, 2024 | -36.39M |
| October 30, 2024 | -32.39M |
| October 29, 2024 | -31.39M |
| October 28, 2024 | -21.38M |
| October 25, 2024 | -28.39M |
| October 24, 2024 | -24.38M |
| October 23, 2024 | -17.38M |
| October 22, 2024 | -34.39M |
| October 21, 2024 | -30.89M |
| October 18, 2024 | -24.38M |
| Date | Value |
|---|---|
| October 17, 2024 | -23.38M |
| October 16, 2024 | -24.38M |
| October 15, 2024 | -25.38M |
| October 14, 2024 | -19.38M |
| October 11, 2024 | -13.37M |
| October 10, 2024 | -14.37M |
| October 09, 2024 | -19.38M |
| October 08, 2024 | -18.38M |
| October 07, 2024 | -17.38M |
| October 04, 2024 | -24.98M |
| October 03, 2024 | -16.38M |
| October 02, 2024 | -18.38M |
| October 01, 2024 | -12.37M |
| September 30, 2024 | -2.363M |
| September 27, 2024 | -9.634M |
| September 26, 2024 | -9.033M |
| September 25, 2024 | -12.04M |
| September 24, 2024 | -7.031M |
| September 23, 2024 | -8.032M |
| September 20, 2024 | -2.327M |
| September 19, 2024 | 3.979M |
| September 18, 2024 | -0.0246M |
| September 17, 2024 | 5.981M |
| September 16, 2024 | 1.977M |
| September 13, 2024 | -3.027M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-41.06M
Minimum
Jun 30 2024
1.203B
Maximum
Jan 19 2021
233.70M
Average
92.49M
Median
Feb 14 2022
Enterprise Value Benchmarks
| Edap TMS SA | 68.17M |
| DBV Technologies SA | 1.221M |
| Genfit SA | 212.18M |
| Adaptimmune Therapeutics PLC | 26.67M |
| Akari Therapeutics PLC | 24.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.06M |
| Revenue (Quarterly) | 16.20M |
| Total Expenses (Quarterly) | 26.97M |
| EPS Diluted (Quarterly) | -0.23 |
| Profit Margin (Quarterly) | -142.3% |
| Earnings Yield | -72.43% |
| Normalized Earnings Yield | -51.30 |